Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
about
Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromesNovel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?Dendritic Cell Therapies for Hematologic Malignancies.Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis.Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment.NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-Lymphocyte Responses in Patients with Myelodysplastic Syndrome.The emerging role of immune checkpoint based approaches in AML and MDS.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses.Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature.NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2',2'-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer.Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
P2860
Q37685237-0097F97D-FFAF-4525-B82D-C8C9ED151523Q38664735-392D82ED-DE6B-4EF9-B8C4-9A793F9F4B0FQ39289930-5120FE6F-A778-47BF-BB07-91F261218294Q39295844-99BC0C71-7148-49E0-B701-10A24E35ACD1Q41573313-D4E2D60B-71B6-4352-ABA8-4E2635C9B585Q47923445-37959C09-6157-4317-850B-65D1BCB058B1Q48173100-CB3B23ED-A142-46D8-83BC-A6673597A46FQ48273861-CC21C3A2-1849-469B-A07E-615F128C80E2Q52676449-BE8E76EA-9432-40C6-BF9F-98CCC7D23DE9Q55364989-E7F64D49-06F2-4E03-A782-628CF5B2E59AQ55644829-30163A26-78D7-4862-B705-AAE7BAB0FE08Q57486479-4DDCE108-77CA-4BBF-9F39-5CFD58E641F5
P2860
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induction of cancer testis ant ...... methylating agent monotherapy.
@en
Induction of cancer testis ant ...... methylating agent monotherapy.
@nl
type
label
Induction of cancer testis ant ...... methylating agent monotherapy.
@en
Induction of cancer testis ant ...... methylating agent monotherapy.
@nl
prefLabel
Induction of cancer testis ant ...... methylating agent monotherapy.
@en
Induction of cancer testis ant ...... methylating agent monotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Induction of cancer testis ant ...... methylating agent monotherapy.
@en
P2093
Benjamin E Paluch
Elizabeth A Griffiths
Golda Collamat-Lai
Junko Matsuzaki
Laurie Ann Ford
Michael J Nemeth
Michael Lübbert
Nadja Blagitko-Dorfs
Pragya Srivastava
Rafeh Naqash
P2860
P304
12840-12856
P356
10.18632/ONCOTARGET.7326
P407
P50
P577
2016-02-11T00:00:00Z